Fidelity Disruptive Medicine ETF (FMED) Institutional Ownership $23.99 +0.09 (+0.38%) As of 07/3/2025 01:04 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisChartDividendHoldingsOwnershipRatingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Fidelity Disruptive Medicine ETF (NASDAQ:FMED)Number ofInstitutional Buyers(last 12 months)2TotalInstitutional Inflows(last 12 months)$4.03MNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$1.74M Get FMED Insider Trade Alerts Want to know when executives and insiders are buying or selling Fidelity Disruptive Medicine ETF stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data FMED Institutional Buying and Selling by Quarter Fidelity Disruptive Medicine ETF Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/19/2025Jane Street Group LLC66,382$1.57M0.0%+0.8%3.161% 4/16/2025Wealth Enhancement Advisory Services LLC612,212$14.45M0.0%+4.9%29.153% 3/17/2025Wealth Enhancement Advisory Services LLC583,615$14.39M0.0%+8.1%27.791% 2/14/2025Jane Street Group LLC65,883$1.63M0.0%+7.4%3.137% 11/15/2024Jane Street Group LLC61,342$1.61M0.0%+200.4%2.921% 11/13/2024FMR LLC663,600$17.45M0.0%-9.1%31.600% 10/24/2024Wealth Enhancement Advisory Services LLC539,827$14.19M0.0%+3.7%25.464% 7/16/2024Wealth Enhancement Advisory Services LLC520,587$12.53M0.0%+4.8%24.556% 4/16/2024Wealth Enhancement Advisory Services LLC496,857$12.68M0.0%+6.3%23.437% 11/13/2023FMR LLC737,997$16.33M0.0%-2.6%34.811% (Data available from 1/1/2016 forward) FMED Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of FMED shares? During the previous two years, the following institutional investors and hedge funds held shares of Fidelity Disruptive Medicine ETF shares: FMR LLC ($17.45M), and Wealth Enhancement Advisory Services LLC ($14.45M), Jane Street Group LLC ($1.57M).Learn more on Fidelity Disruptive Medicine ETF's institutional investors. Which institutional investors have been buying Fidelity Disruptive Medicine ETF's stock? The following institutional investors have purchased Fidelity Disruptive Medicine ETF's stock in the last 24 months: Wealth Enhancement Advisory Services LLC ($144.69K), and Jane Street Group LLC ($45.96K). How much institutional buying is happening at Fidelity Disruptive Medicine ETF? Institutional investors have bought a total of 161,319 shares in the last 24 months. This purchase volume represents approximately $4.03M in transactions. Which of Fidelity Disruptive Medicine ETF's major shareholders have been selling company stock? The following institutional investors have sold Fidelity Disruptive Medicine ETF stock in the last 24 months: FMR LLC ($66.24K). How much institutional selling is happening at Fidelity Disruptive Medicine ETF? Institutional investors have sold a total of 66,239 shares in the last 24 months. This volume of shares sold represents approximately $1.74M in transactions. Related Companies FDFF Institutional Ownership XAIX Institutional Ownership HRTS Institutional Ownership AGNG Institutional Ownership SPRX Institutional Ownership SETM Institutional Ownership BLCN Institutional Ownership SARK Institutional Ownership GNOM Institutional Ownership TARK Institutional Ownership This page (NASDAQ:FMED) was last updated on 7/5/2025 by MarketBeat.com Staff From Our PartnersTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredThe $15 Gold Fund That Pays Up to $1,152/MonthGold prices are breaking records. But while everyone else is fixated on headlines… They're missing somet...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Fidelity Disruptive Medicine ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Fidelity Disruptive Medicine ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
